Home -> Law Blog Directory -> Intellectual Property Law Blogs -> Two-Seventy-One Patent Blog
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Intellectual Property Law
: Two-Seventy-One Patent BlogStartups Push Congress to Maintain One-Year "Grace Period" for Patent Reform
By Peter Zura
Without the grace period, the patent system would become far more expensive and less effective for small companies. It would create the need to ?race to the patent office? more frequently and at great expense before every new idea is fully developed or vetted. The pressure for more filings will affect all American inventors ? not only a few that end up in interferences under current law. Because filing decisions must be made based on information that will be preliminary and immature, the bill forces poor patenting decisions. Applicants will skip patent protection for some ultimately valuable inventions, and will bear great costs for applications for inventions that (with the additional information that is developed during the grace period year of current law) prove to be useless, and subsequently abandoned. The evidence for this high abandonment trend under systems having no grace period is readily available from European application statistics.Read the letter in its entirety here (link)The proponents of S. 515 suggest that the harm of the weak grace period of proposed § 102(b) can be overcome if an inventor publishes a description of the invention, allowing filing within a year following such publication. Underlying this suggestion are two errors. First, no business willingly publishes complete technical disclosures that will tip-off all competitors to a company?s technological direction. We generally do not, and will not, publish our inventions right when we make them, some 2.5 years before the 18-month publication or 5-7 years before the patent grant. Confidentiality is crucial to small companies.
Second, even if we were to avail ourselves of such conditional grace period by publishing first before filing, we would instantly forfeit all foreign patent rights because such publication would be deemed prior art under foreign patent law. No patent attorney will advise their client to publish every good idea they conceive in order to gain the grace period of S. 515. The publication-conditioned ?grace period? in S. 515 is a useless construct proposed by parties intent on compelling American inventors to ?harmonize? de facto with national patent systems that lack grace periods. S. 515 forces U.S. inventors to make the ?Hobson?s Choice? of losing their foreign patent rights or losing the American grace period. It should be clear that the only way for American inventors to continue to benefit from a grace period and be able to obtain foreign patent rights, is to keep intact the current secret grace period that relies on invention date and a diligent reduction to practice.
See EETimes, "Startups petition Congress on patent reform" (link)
See also David Boundy letter of February 1, 2010:
Under the amendment to 35 U.S.C. § 102 proposed in S.515, the one-year grace period becomes extremely fragile?every business must assume there is no grace period, and that an application must be filed before any discussion of the invention with any other investor or strategic partner. S.515?s weak grace period will impose huge costs on every innovator that cannot assemble all necessary financial, R&D, manufacturing and marketing resources within a single firm, or that has to do significant testing outside the firm. Independent inventors, startups, and university inventors will be forced to make ?use it or lose it? patent decisions about a year earlier than under current law, which in turn will require filing of many more patent applications. Each application drains many thousands of dollars of capital from productive uses to speculative patent filings, many of which will turn out to be useless. S.515 will strangle many companies in their cribs, by sucking capital out to the patent attorneys.
Full post as published by Two-Seventy-One Patent Blog on May 04, 2010 (boomark / email).
Zantac Patent
GlaxoSmithKline and Cypress Pharmaceutical settle patent infringement dispute.
Texas, USA
alleging the Medical Malpractice and Tort Reform Act of 2003 violates several provisions of the Constitution.
Soliris Patent
Alexion Pharmaceuticals Inc. agrees to pay the Oklahoma Medical Research Foundation a $10 million patent infringement settlement.
WR Grace
Reaches $140 Million Settlement in Zonolite Insulation Class Action
DRAM Patent
ProMOS Technologies and Mosel Vitelic pay MOSAID Technologies an undisclosed patent infringement settlement.
82 Year Old
Awarded $6 Million in SJS Lawsuit

Senate Patent Reform Bill on Prior Art Grace Period
New time limit for grace period for renewal of registration
Suggestions for Patent Reform in the 111th US Congress.
US Debates Patent Exam Deferrals; Patent Reform Bill Expected This Year








